Momelotinib is a pharmaceutical raw material used in the manufacturing of medications for myelofibrosis. It functions as a Janus kinase inhibitor and is administered orally.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Peficitinib
pharmaceutical raw material
Baricitinib
pharmaceutical raw material
Upadacitinib
pharmaceutical raw material
Fingolimod
pharmaceutical raw material
Fingolimod hydrochloride
pharmaceutical raw material
Roflumilast
pharmaceutical raw material
3-Methoxy-4-(difluoromethoxy)benzaldehyde
pharmaceutical raw material
Despropanesulfonyl Abrocitinib
pharmaceutical intermediate
The international HS code for N-(cis-3-(Methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)-1-propanesulfonamide (CAS 1622902-68-4) is 2935.90.
2935.90
2935 90 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
N-[3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide
IUEWXNHSKRWHDY-UHFFFAOYSA-N
CCCS(=O)(=O)NC1CC(C1)N(C)C2=NC=NC3=C2C=CN3
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.